Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open Label, Neoadjuvant Study of Bevacizumab in Patients With Inflammatory or Locally Advanced Breast Cancer

NCT00559845 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00559845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open Label, Neoadjuvant Study of Bevacizumab in Patients With Inflammatory or Locally Advanced Breast Cancer
Lead sponsor
Hoffmann-La Roche
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
July 31, 2015
Enrollment
56 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer